NSF acquires IPEC auditing arm
NSF International has acquired the auditing subsidiary of the International Pharmaceutical Excipients Council of the Americas (IPEC) as part of a way to ensure a more streamlined supplier qualification process.
Archives for February 11, 2014
Pharmarama CEO: ‘We are the supply chain’
“Traffic companies” which source medicines for clinical trials are an unsung but essential phase of safe supply chains, according to Pharmarama.
Excipact scheme launched as independent not-for-profit alliance
The team behind the scheme that helped BASF, Seppic and Merck KGaA reduce their audit burdens expect more excipient suppliers to seek certification as an independent association.
NIH partners with 10 pharma companies to tackle major disease targets
The National Institutes of Health and 10 pharmaceutical companies have launched a partnership to transform the current model for identifying and validating promising biological targets for Type 2 diabetes, Alzheimer’s disease, lupus and rheumatoid arthritis.
EU updates GMP principles on qualification and validation
European drug manufacturers will have to control the critical aspects of their operations through qualification and validation over the lifecycle of the product and process, according to a new draft GMP guideline from the European Commission.
ACRO head: 'Accessing global population accelerates drug development'
In an exclusive Q&A, new ACRO Chairman Ciaran Murray says conducting trials in countries such as China and India is critically important for speeding up drug development.